Bottom line
How much do IBBQ and FBDIX overlap?
38% of their top holdings overlap by weight. 10 securities appear in both funds' top 25, making up 36.8% of IBBQ's assets and 30.4% of FBDIX's. They share a meaningful core but differ in the rest of the portfolio.
IBBQ holds far more positions (261 vs 126), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IBBQ and FBDIX have in common
| Holding | % of IBBQ | % of FBDIX | Overlap |
|---|---|---|---|
| Gilead Sciences, Inc. | 7.39% | 3.86% | 3.86% |
| Vertex Pharmaceuticals Inc. | 7.38% | 3.54% | 3.54% |
| Amgen Inc. | 7.10% | 4.39% | 4.39% |
| Regeneron Pharmaceuticals, Inc. | 5.08% | 3.77% | 3.77% |
| Revolution Medicines, Inc. | 2.48% | 3.01% | 2.48% |
| argenx SE | 1.89% | 3.62% | 1.89% |
| Insmed Inc. | 1.83% | 1.99% | 1.83% |
| Guardant Health, Inc. | 1.35% | 2.76% | 1.35% |
| Neurocrine Biosciences, Inc. | 1.26% | 1.82% | 1.26% |
| BridgeBio Pharma, Inc. | 1.02% | 1.67% | 1.02% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IBBQ
- Invesco Private Prime Fund — 14.20%
- Invesco Private Government Fund — 5.48%
- Alnylam Pharmaceuticals, Inc. — 3.19%
- Biogen Inc. — 2.29%
- Illumina, Inc. — 1.98%
- United Therapeutics Corp. — 1.94%
- Royalty Pharma PLC — 1.90%
- Roivant Sciences Ltd. — 1.71%
- Incyte Corp. — 1.53%
- Viatris Inc. — 1.49%
- Moderna, Inc. — 1.48%
- Jazz Pharmaceuticals PLC — 1.16%
- Ascendis Pharma A/S — 1.10%
- Summit Therapeutics Inc. — 1.08%
- Exelixis, Inc. — 1.04%
Only in FBDIX
- Jazz Pharmaceuticals plc — 5.66%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Ascendis Pharma A/S — 2.56%
- Dianthus Therapeutics, Inc. — 2.32%
- Mirum Pharmaceuticals, Inc. — 1.98%
- Praxis Precision Medicines, Inc. — 1.91%
- Spyre Therapeutics, Inc. — 1.87%
- Oruka Therapeutics, Inc. — 1.86%
- PTC Therapeutics, Inc. — 1.65%
- AstraZeneca plc — 1.51%
- Franklin Institutional U.S. Government Money Market Fund — 1.45%
- Amylyx Pharmaceuticals, Inc. — 1.32%
- Eli Lilly & Co. — 1.31%
- Cytokinetics, Inc. — 1.24%
- Tango Therapeutics, Inc. — 1.23%
Asset mix
| Asset type | IBBQ | FBDIX |
|---|---|---|
| Stocks | 99.9% | 97.0% |
| Cash & short-term funds | 19.7% | 4.6% |
| Preferred stock | — | 1.0% |
| Other | — | 0.6% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | IBBQ | FBDIX |
|---|---|---|
| US | 103.8% | 82.0% |
| IE | 1.9% | 6.7% |
| NL | 2.5% | 4.5% |
| GB | 2.7% | 1.5% |
| DK | 1.2% | 2.6% |
| FR | 1.5% | 1.7% |
| BM | 1.7% | — |
| CA | 0.9% | 1.3% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IBBQ and FBDIX overlap?
What stocks do IBBQ and FBDIX have in common?
Should I own both IBBQ and FBDIX?
Which holds more stocks, IBBQ or FBDIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.